Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial 1B-16-9
COMPLEEMENT-1: An open-label, multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination with Letrozole for the Treatment of men and Postmenopausal Women with Hormone Receptorpositive (HR+) HER2-negative (HER2-) Advanced Breast cancer (aBC) with no prior Hormonal Therapy for Advanced Disease
Type:
Treatment
Phase:
Phase III
Status:
Not Open (Closed)
Treatments:
Hormone, Other
Randomized:
No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Janice Lu, M.D.
Other Trial Staff:
Richa Aggarwal, D.M., Monica Flores, D.M., Victoria Banerjee, R.N., Grace Facio, R.N., Margarita Carranza, D.M., America Casillas-Lopez, Coordinator, Kristy Watkins, R.N.
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.